10x Genomics announced several changes to its executive team. Justin McAnear, CFO, will resign from the company effective August 30, to join a private company. Adam Taich has been appointed CFO, effective August 12. Taich will be responsible for leading the company’s financial team and strategy. Mennah Moustafa has been named Chief Commercial Officer, effective August 1. In this role, Moustafa will be responsible for driving commercial strategy and execution and leading the company’s sales, support and marketing functions.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TXG:
- 10x Genomics Reports Second Quarter 2024 Financial Results
- 10x Genomics announces involvement in TenK10K
- Cathie Wood’s ARK Investment buys 392.5K shares of 10x Genomics today
- Cathie Wood’s ARK Investment buys 122K shares of 10x Genomics today
- 10x Genomics price target lowered to $32 from $50 at Canaccord